
Auctus – SUCCESS PAGE – November 19, 2025
Auctus Vertical Body Tethering has received a Breakthrough Device Designation and Humanitarian Device Exemption Pathway from the FDA

Auctus Vertical Body Tethering has received a Breakthrough Device Designation and Humanitarian Device Exemption Pathway from the FDA

BrainScope has a pipeline that spans stroke, Alzheimer’s, concussion, and beyond, and is uniquely positioned in a $21B+ global market

Breakthru Medicine is developing precision cancer therapies targeting an $18B+ solid cancer market with massive unmet need

Auctus Vertical Body Tethering has received a Breakthrough Device Designation and Humanitarian Device Exemption Pathway from the FDA

General Oncology, Inc., is advancing late-stage oncology and ophthalmology programs with human proof-of-concept data and a defined path to liquidity.

BrainScope has a pipeline that spans stroke, Alzheimer’s, concussion, and beyond, and is uniquely positioned in a $21B+ global market

Hummingbird Tympanostomy Tube System enables ear tube placement for children at a doctor’s office in just minutes, dramatically reducing healthcare costs

Hummingbird Tympanostomy Tube System enables ear tube placement for children at a doctor’s office in just minutes, dramatically reducing healthcare costs

General Oncology, Inc., is advancing late-stage oncology and ophthalmology programs with human proof-of-concept data and a defined path to liquidity.

Araceli’s ultra-high-throughput imaging platform is poised to become the backbone of AI-driven drug discovery and therapeutics.

Araceli’s ultra-high-throughput imaging platform is poised to become the backbone of AI-driven drug discovery and therapeutics.

Gene therapy stands at the forefront of medical innovation, offering the potential to not only treat but also cure a wide range of genetic disorders.